Works matching IS 20474873 AND DT 2022 AND VI 29 AND IP 14
Results: 23
Effect of mineralocorticoid receptor antagonist at baseline on the efficacy of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a meta-analysis of randomized controlled trials.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Lipoprotein(a) testing in clinical practice: real-life data from a large healthcare provider.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Reduction in blood pressure for elevated blood pressure/stage 1 hypertension according to the American College of Cardiology/American Heart Association guideline and cardiovascular outcomes.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1921, doi. 10.1093/eurjpc/zwac193
- By:
- Publication type:
- Article
Effect of acetaminophen on blood pressure: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Timing of statin dose: a systematic review and meta-analysis of randomized clinical trials.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Erratum to: Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: Supraventricular arrhythmias. A position statement of the Section of Sports Cardiology and Exercise from the European Association of Preventive Cardiology (EAPC) and the European Heart Rhythm Association (EHRA), both associations of the European Society of Cardiology
- Published in:
- 2022
- Publication type:
- Correction Notice
Corrigendum to: The promise and challenge of telerehabilitation in cardiac rehabilitation.
- Published in:
- 2022
- Publication type:
- Correction Notice
Corrigendum to: Benjamin D Levine, Edward D Nicol, Constantinos H Davos, Space: the final frontier?, European Journal of Preventive Cardiology , 2022; zwac125, https://doi.org/10.1093/eurjpc/zwac125.
- Published in:
- 2022
- Publication type:
- Correction Notice
High visit-to-visit cholesterol variability predicts heart failure and adverse cardiovascular events: a population-based cohort study.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1911, doi. 10.1093/eurjpc/zwac192
- By:
- Publication type:
- Article
Vegetarianism, microbiota, and cardiovascular health: looking back, and forward.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1895, doi. 10.1093/eurjpc/zwac128
- By:
- Publication type:
- Article
The gut microbiota's role in diet-related cardiovascular health: an innocent bystander or a key mediator; the question remains.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1881, doi. 10.1093/eurjpc/zwac152
- By:
- Publication type:
- Article
Influenza vaccination: a call for cardiologists.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Lipid cutoffs for increased cardiovascular disease risk in non-diabetic young people.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1866, doi. 10.1093/eurjpc/zwac139
- By:
- Publication type:
- Article
Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1854, doi. 10.1093/eurjpc/zwac122
- By:
- Publication type:
- Article
The role of histamine H2 receptor antagonist in heart failure: a potential game-changer?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1842, doi. 10.1093/eurjpc/zwac107
- By:
- Publication type:
- Article
Towards more personalized low-density lipoprotein cholesterol lowering strategies in patients with atherosclerotic cardiovascular disease.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017–2020.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1830, doi. 10.1093/eurjpc/zwac103
- By:
- Publication type:
- Article
Cardiovascular prevention with statins: epidemiological considerations.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial comments: Focus on pharmacological management.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Medications for blood pressure, blood glucose, lipids, and anti-thrombotic medications: relationship with cardiovascular disease and death in adults from 21 high-, middle-, and low-income countries with an elevated body mass index.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1817, doi. 10.1093/eurjpc/zwac069
- By:
- Publication type:
- Article